Literature DB >> 696680

Rhabdomyosarcomas of the uterus.

W R Hart, J R Craig.   

Abstract

The authors report the clinicopathologic findings in four cases of adult women with rhabdomyosarcomas that originated in the endometrium or cervix, or both. All tumors were pure sarcomas and not components of carcinosarcomas or malignant mixed mesodermal tumors. In two patients, the tumors were typical botryoid embryonal rhabdomyosarcomas. Both patients were alive and well following combined treatments with surgery and chemotherapy or irradiation 3.0 and 2.7 years after operation, respectively, although one had a solitary pulmonary metastasis resected. The other two women had pleomorphic rhabdomyosarcomas, and both died rapidly of widespread tumor. Combination therapy rather than surgery alone probably should be used initially for patients with rhabdomyosarcomas of the uterus.

Entities:  

Mesh:

Year:  1978        PMID: 696680     DOI: 10.1093/ajcp/70.2.217

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal patient.

Authors:  Katalin Borka; Kálmán Patai; Anikó Rendek; Gábor Sobel; Ferenc Paulin
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

2.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

Review 3.  [A rare cases of rhabdomyosarcoma of the uterine cervix: about a case and review of the literature].

Authors:  Hamza Samlali; Hassan Jouhadi; Hicham Attar; Souha Sahraoui; Abdellatif Benider
Journal:  Pan Afr Med J       Date:  2016-11-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.